Furthermore, increased serum levels of FGF23 are associated with a greater risk of left ventricular hypertrophy (8), heart failure (9), and atrial fibrillation (10) and are also independently associated with increased mortality in chronic kidney disease (CKD). Here, FGF23 is linked to chronic kidney disease.